• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

InterMune Inc

+ Add to Watchlist


56.970 EUR 0.080 0.14%

As of 08:52:51 ET on 09/19/2014.

Snapshot for InterMune Inc (IUX)

Open: 56.385 Day's Range: 56.385 - 57.210 Volume: 20
Previous Close: 57.050 52wk Range: 8.195 - 58.200 1-Yr Rtn: +408.12%

Stock Chart for IUX

No chart data available.
  • IUX:GR 56.970
  • 1D
  • 1M
  • 1Y
Interactive IUX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IUX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.7470
Est. PEG Ratio -
Market Cap (M EUR) 6,151.00
Shares Outstanding (M) 107.97
30 Day Average Volume 1,797
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IUX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IUX

InterMune, Inc. is a biotechnology company. The Company's focus is on the research, development and commercialization of therapies in pulmonology and fibrotic diseases. InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor pulmonary and fibrotic diseases.

Daniel G Welch "Dan"Chairman/President/CEOJohn HodgmanExec VP/CFO
Sean P NolanExec VP/Chief Business OfficerGiacomo Di NepiExec VP/Managing Dir:Europe
More Company Profile & Key Executives for IUX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil